10x Genomics (TXG) Cash & Equivalents (2018 - 2026)
10x Genomics (TXG) posted Cash & Equivalents of $490.3 million for Q1 2026, up 3.44% sequentially from $474.0 million in Q4 2025, and up 30.03% YoY from $377.1 million in Q1 2025.
10x Genomics (TXG) Cash & Equivalents (2018 - 2026) Analysis & Trends
10x Genomics has reported Cash & Equivalents for 9 years, with the latest figure at $490.3 million in Q1 2026.
- Quarterly Cash & Equivalents rose 30.03% year-over-year to $490.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $490.3 million (up 30.03% YoY) and the FY2025 annual result came in at $474.0 million, up 37.75% from the prior year.
- Cash & Equivalents improved to $490.3 million in Q1 2026 per TXG's latest filing, from $474.0 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $490.3 million in Q1 2026 and troughed at $219.7 million in Q4 2022.
- A 5-year average of $354.0 million and a median of $355.8 million in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents slumped 62.59% in 2022, then surged 63.5% in 2023.
- Over 5 years, Cash & Equivalents stood at $219.7 million in 2022, then surged by 63.5% to $359.3 million in 2023, then decreased by 4.24% to $344.1 million in 2024, then soared by 37.75% to $474.0 million in 2025, then increased by 3.44% to $490.3 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $490.3 million, $474.0 million, and $432.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 1.90 Bn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 550.38 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 265.37 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 502.51 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 286.22 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 298.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 12.65 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 273.60 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 246.80 Mn |
| 10 | Privia Health | 2.78 Bn | 2.42 Bn | - | 412.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 502.51 Mn |
| Mar 31, 2026 | 490.29 Mn |
| Dec 31, 2025 | 473.97 Mn |
| Sep 30, 2025 | 432.51 Mn |
| Jun 30, 2025 | 397.71 Mn |
| Mar 31, 2025 | 377.06 Mn |
| Dec 31, 2024 | 344.07 Mn |
| Sep 30, 2024 | 398.16 Mn |
| Jun 30, 2024 | 379.82 Mn |
| Mar 31, 2024 | 355.78 Mn |
| Dec 31, 2023 | 359.28 Mn |
| Sep 30, 2023 | 311.26 Mn |
| Jun 30, 2023 | 325.88 Mn |
| Mar 31, 2023 | 332.32 Mn |
| Dec 31, 2022 | 219.75 Mn |
| Sep 30, 2022 | 233.95 Mn |
| Jun 30, 2022 | 274.19 Mn |
| Mar 31, 2022 | 312.49 Mn |
| Dec 31, 2021 | 587.45 Mn |
| Sep 30, 2021 | 600.44 Mn |